Tag: Competition

Displaying 81 - 100 of 2722 results.

Pages

Physicians’ practices vary widely, as do their effectiveness and reimbursement. Using a merger of six orthopaedic groups in southeastern Pennsylvania, we find that such groups can generate large, anti‐competitive price increases without any demonstrated increases in quality (...
Bruce Hoffman, the Acting Director of the Federal Trade Commission’s Bureau of Competition, issued this statement on the Commission’s decision not to further pursue an investigation of Amazon.com, Inc.’s acquisition of Whole Foods Market Inc.:
The National Association of Animal Breeders, Inc., or NAAB – a non-profit trade association whose members compete to sell dairy cattle semen to U.S. dairy farms for artificial insemination of dairy cows – has agreed to refrain from adopting rules that unreasonably stifle competition among its...
Following a public comment period, the Federal Trade Commission has approved a final order designed to remedy the anticompetitive effects resulting from Broadcom Limited’s acquisition of Brocade Communications Systems, Inc. Under the consent order, Broadcom is required to implement firewalls...
Following a public comment period, the Federal Trade Commission has approved a final order resolving charges that Alimentation Couche-Tard Inc.’s $4.4 billion acquisition of CST Brands, Inc. would violate federal antitrust laws. The order requires ACT to divest retail fuel stations with convenience...
The Federal Trade Commission has closed its investigation of several agreements between Honeywell International, Inc. and E.I. DuPont de Nemours & Co.1 related to the sale of 1234yf, the next generation refrigerant in automotive air conditioning systems.
Following a public comment period, the Federal Trade Commission has approved a final order resolving concerns that the acquisition of the Valspar Corporation by The Sherwin-Williams Company would likely allow the new company to exercise unilateral market power in the North American market for...
In testimony presented to the U.S. House of Representatives’ Judiciary Committee Subcommittee on Regulatory Reform, Commerical and Antitrust Law, the Federal Trade Commission described its efforts to stop anticompetitive conduct in the pharmaceutical industry.
WHAT:The U.S. Federal Trade Commission will host a Roundtable, Streamlining Licensing Across State Lines: Initiatives to Enhance Occupational License Portability. The event will explore options for enhancing the portability of occupational licenses.WHEN:Thursday, July 27, 2:00 p.m.–4:00 p.m.
Federal Trade Commission Acting Chairman Maureen K. Ohlhausen released a summary of the agency’s major accomplishments since President Trump named her to the position in January. “I have pursued my long-held principles by promoting economic liberty, protecting consumers (including the military...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business would (1) reduce current competition in the United States for the...
Baxter International Inc. and Claris Lifesciences Limited have agreed to divest two types of pharmaceutical products to settle Federal Trade Commission charges that Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business is anticompetitive.According to a complaint filed by...

Pages